Diagnostic Autonomic denied due to quantity / dose limits by Cigna?

Cigna's specific coverage criteria for diagnostic autonomic are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denied Autonomic Diagnostic Testing Due to Quantity Limits

Quantity-limit denials for autonomic diagnostic testing typically arise when Cigna's coverage policy restricts the number of times a specific autonomic study (e.g., tilt-table test, QSART, cardiovascular autonomic reflex studies) can be performed within a defined period — commonly per year or per diagnosis. The denial may mean a test was performed a second time when the plan considers one study sufficient, or that multiple component tests billed together exceeded a bundled limit. Check the EOB for the specific CPT codes denied and the plan's quantity-limit schedule.

## Why This Denial Is Appealable

Quantity limits are usually set by payers as default rules for the average patient, but individual clinical circumstances frequently justify exceptions. Common grounds for appeal include: the prior study was performed at a different facility and results are not comparable; the patient's condition has materially changed since the prior test, warranting re-evaluation; a different component of the autonomic battery was being tested than what was covered previously; or the clinical standard of care for the patient's specific condition requires serial monitoring. Your prescribing or treating physician is the key witness for these arguments.

## Federal Appeal Framework

Under ACA Section 2719 and ERISA Section 503, quantity-limit denials are adverse benefit determinations subject to mandatory internal appeal and, if upheld, independent external review. File the internal appeal within the deadline on the denial notice (typically 180 days). After a final internal denial, you generally have four months to request external review. If the additional testing is urgently needed, request expedited external review — a decision is required within 72 hours.

## Documentation to Gather

• Prior test records: Dates, CPT codes, and results of any prior autonomic studies to establish what was already performed and why it is insufficient for the current clinical question.
• Change-in-condition documentation: Chart notes documenting a new symptom, progression, or clinical event that makes repeat testing necessary.
• Physician justification letter: A letter from the treating physician explaining why the quantity limit is clinically inappropriate for this specific patient — without asserting that any specific numeric threshold in Cigna's policy is wrong, but instead demonstrating why the patient's individual circumstances warrant an exception.
• Applicable guideline reference: A generic citation to the professional society guideline (e.g., American Autonomic Society, American Academy of Neurology) supporting serial or repeated testing in the clinical scenario at issue.

## Criteria-Mapping Structure

| Cigna's Quantity-Limit Rule | Patient-Specific Exception Basis | |---|---| | [State the limit as written in the plan/policy] | [Specific clinical reason this patient's situation requires an exception, with chart citation] |

Request a copy of the applicable quantity-limit schedule from Cigna before submitting the appeal so you can address the precise rule that was applied.